MR-based coronary artery blood velocity measurements in patients without coronary artery disease

M Schiemann1, F Bakhtiary, V Hietschold

  • 1Institute of Diagnostic and Interventional Radiology University Hospital, Johann Wolfgang Goethe-University, Frankfurt am Main, Germany.

European Radiology
|January 18, 2006
PubMed

Insights

Magnetic resonance-based coronary blood velocity measurements (MRvenc) are feasible for quantifying blood flow in coronary arteries. This technique shows potential for monitoring patients post-aortic valve surgery and detecting asymptomatic coronary artery disease (CAD).

Area of Science:

  • Cardiovascular Imaging
  • Medical Physics

Background:

  • Coronary artery disease (CAD) diagnosis often relies on invasive procedures.
  • Non-invasive methods for assessing coronary blood flow are crucial for early detection and monitoring.
  • Magnetic resonance imaging (MRI) offers a non-invasive approach to visualize and quantify cardiovascular parameters.

Purpose of the Study:

  • To assess the feasibility of MR-based coronary blood velocity measurements (MRvenc) in patients without obstructive coronary artery disease (CAD).
  • To quantify systolic and diastolic blood velocities in the coronary arteries (CAs) using MRvenc.
  • To explore potential clinical applications of MRvenc in cardiovascular patient management.

Main Methods:

  • Eighty-three patients with angiographically excluded CAD underwent MRvenc of proximal coronary arteries.
  • A retrospectively ECG-gated, breath-hold, phase-contrast FLASH sequence with high temporal resolution was employed.
  • Blood velocity quantification and analysis of velocity profiles in systole and diastole were performed for left and right coronary arteries (LCA and RCA).

Main Results:

  • Flow data were technically acquirable in 83% (137/166) of CAs.
  • Biphasic velocity profiles, indicative of normal flow, were observed in 83% of analyzed CAs.
  • Significant differences in median systolic and diastolic velocities were found in both LCA and RCA (P<0.0001 and P<0.01, respectively).
  • The diastolic/systolic velocity ratio was 1.3 for LCA and 1.1 for RCA.
  • Monophasic or altered velocity profiles were noted in the remaining CAs.

Conclusions:

  • Optimized clinical MRvenc is a feasible technique for quantifying coronary artery blood velocities non-invasively.
  • MRvenc holds potential for monitoring patients after aortic valve reconstruction.
  • MRvenc may aid in the detection of asymptomatic CAD patients, enabling earlier intervention.